FAST RADIUS INC (FSRD)

US31187R1005 - Common Stock

0.14  -0.07 (-33.33%)

After market: 0.132 -0.01 (-5.71%)

Fundamental Rating

1

Taking everything into account, FSRD scores 1 out of 10 in our fundamental rating. FSRD was compared to 132 industry peers in the Machinery industry. FSRD has a bad profitability rating. Also its financial health evaluation is rather negative. FSRD is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

In the past year FSRD has reported negative net income.
FSRD had a negative operating cash flow in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -181.77%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -391.8%
PM (TTM) -375.62%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

FSRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FSRD remains at a similar level compared to 1 year ago.
The debt/assets ratio for FSRD is higher compared to a year ago.

2.2 Solvency

FSRD has an Altman-Z score of -9.90. This is a bad value and indicates that FSRD is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.40 indicates that FSRD is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z -9.9
ROIC/WACCN/A
WACC7.69%

2.3 Liquidity

A Current Ratio of 1.13 indicates that FSRD should not have too much problems paying its short term obligations.
A Quick Ratio of 1.12 indicates that FSRD should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.12

3

3. Growth

3.1 Past

FSRD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -213.24%.
The Revenue has grown by 43.29% in the past year. This is a very strong growth!
EPS 1Y (TTM)-213.24%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-41.85%
Revenue 1Y (TTM)43.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q49.48%

3.2 Future

The Earnings Per Share is expected to decrease by -8.87% on average over the next years.
FSRD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 39.63% yearly.
EPS Next Y-65.72%
EPS Next 2Y-8.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year45.45%
Revenue Next 2Y39.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FSRD. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FSRD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.01

4.3 Compensation for Growth

FSRD's earnings are expected to decrease with -8.87% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.87%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

FSRD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FAST RADIUS INC

NASDAQ:FSRD (11/17/2022, 7:19:18 PM)

After market: 0.132 -0.01 (-5.71%)

0.14

-0.07 (-33.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.57M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -181.77%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -391.8%
PM (TTM) -375.62%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.13
Quick Ratio 1.12
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-213.24%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-65.72%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)43.29%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y